Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rosa Yáñez Baña"'
Autor:
Diego Santos García, Maria Gema Alonso Losada, Icíar Cimas Hernando, Iria Cabo López, Rosa Yáñez Baña, Ruben Alonso Redondo, Jose Manuel Paz González, Carlos Cores Bartolomé, Maria José Feal Painceiras, Maria Cristina Íñiguez Alvarado, Carmen Labandeira, Iago García Díaz
Publikováno v:
Brain Sciences, Vol 12, Iss 11, p 1466 (2022)
Depression is frequent in Parkinson’s disease (PD) patients, but the evidence for many antidepressant agents to treat it in PD is insufficient. The aim of the present prospective open-label single-arm study (VOPARK, an open-label study of the effec
Externí odkaz:
https://doaj.org/article/592b89f8143f4d8aa223be95f6b95834
Autor:
Diego Santos García, Rosa Yáñez Baña, Carmen Labandeira Guerra, Maria Icíar Cimas Hernando, Iria Cabo López, Jose Manuel Paz González, Maria Gema Alonso Losada, Maria José Gonzalez Palmás, Carlos Cores Bartolomé, Cristina Martínez Miró
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 8, p 798 (2021)
Background and objective: Pain is a frequent and disabling symptom in Parkinson’s disease (PD) patients. Our aim was to analyze the effectiveness of safinamide on pain in PD patients from the SAFINONMOTOR (an open-label study of the effectiveness o
Externí odkaz:
https://doaj.org/article/d97200329e034b6fba0fb52ca4efb808
Autor:
Diego Santos García, Carmen Labandeira Guerra, Rosa Yáñez Baña, Maria Icíar Cimas Hernando, Iria Cabo López, Jose Manuel Paz Gonález, Maria Gemma Alonso Losada, María José González Palmás, Cristina Martínez Miró
Publikováno v:
Brain Sciences, Vol 11, Iss 3, p 316 (2021)
Some studies observed a benefit of Parkinson’s disease (PD) patients after treatment with safinamide in some non-motor symptoms (NMSs). The aim of this study was to analyze the effectiveness of safinamide on NMS burden in PD. SAFINONMOTOR (an open-
Externí odkaz:
https://doaj.org/article/2804ab9f10a14886b107b8be9c218623
Autor:
Carmen M. Labandeira, Diego Santos García, Cristina Martínez Miró, Jose Manuel Paz González, Maria G. Alonso Losada, Maria Icíar Cimas Hernando, Maria José Gonzalez Palmás, Rosa Yáñez Baña, Iria Cabo López
Publikováno v:
Advances in Therapy
Introduction Mood disorders are frequent in Parkinson’s disease (PD) and a favorable effect of safinamide on mood has been observed. We aimed to analyze the effectiveness of safinamide on mood as a secondary objective from the SAFINONMOTOR (an open
Autor:
Diego Santos García, Carmen Labandeira Guerra, Rosa Yáñez Baña, Iria Cabo López, Maria Icíar Cimas Hernando, Jose Manuel Paz González, Maria G. Alonso Losada, Maria José Gonzalez Palmás, Carlos Cores Bartolomé, Cristina Martínez Miró
Publikováno v:
Neurological Sciences
Background and objective Some studies observed a benefit of PD patients after treatment with safinamide in some non-motor symptoms. Our aim was to analyze the effectiveness of safinamide on sleep and daytime sleepiness in Parkinson’s disease (PD) p
Autor:
Maria Icíar Cimas Hernando, Maria Gemma Alonso Losada, Jose Manuel Paz Gonález, Maria José Gonzalez Palmás, Iria Cabo López, Carmen Labandeira Guerra, Cristina Martínez Miró, Rosa Yáñez Baña, Diego Santos García
Publikováno v:
Brain Sciences
Volume 11
Issue 3
Brain Sciences, Vol 11, Iss 316, p 316 (2021)
Volume 11
Issue 3
Brain Sciences, Vol 11, Iss 316, p 316 (2021)
Some studies observed a benefit of Parkinson´s disease (PD) patients after treatment with safinamide in some non-motor symptoms (NMSs). The aim of this study was to analyze the effectiveness of safinamide on NMS burden in PD. SAFINONMOTOR (an open-l
Autor:
Carmen Labandeira Guerra, Diego Santos García, Jose Manuel Paz González, Maria José Gonzalez Palmás, Iria Cabo López, Cristina Martínez Miró, Maria Icíar Cimas Hernando, Maria G. Alonso Losada, Rosa Yáñez Baña, Carlos Cores Bartolomé
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 798, p 798 (2021)
Journal of Personalized Medicine
Volume 11
Issue 8
Journal of Personalized Medicine
Volume 11
Issue 8
Background and objective: Pain is a frequent and disabling symptom in Parkinson’s disease (PD) patients. Our aim was to analyze the effectiveness of safinamide on pain in PD patients from the SAFINONMOTOR (an open-label study of the effectiveness o
Autor:
Joan Baiges Octavio, Albert Planas Comes, Francesc Miquel Rodríguez, Ivana Zamarbide Capdepon, Rosa Yáñez Baña, Jorge Hernández Vara, Dulce Campos Blanco, Ángel Sesar Ignacio, Belén Castaño García, Víctor Pérez de Colosía Rama, Caridad Valero Merino, José Obeso Inchausti, Julia Vaamonde Gamo, Alfonso Castro García, J. Gonzalez, Inés Legarda Ramirez, Dolores Sevillano García, Jesús Olivares Romero, Dolores Mateo González, Víctor Puente Periz, Isabel Pérez López-Fraile, Ramón Ibáñez Alonso, Pablo Mir, Begoña Ares Pensado, Maria Cruz Rodriguez Oroz, Elena Lezcano García, Santiago Giménez-Roldán, Manuel Carballo Cordero, José Rafael Chacón Peña, Pilar Granés Ibáñez, Anna Espino Ibáñez, Felix Jimenez, Fernando Alonso Frech, José Suárez Muñoz, Jerzy Krupinski, Berta Pascual Sedano, José Miguel Velázquez Pérez, José Olivé Plana, Juan Carlos Martínez-Castrillo, Francesc Valldeoriola Serra, Mercedes Álvarez López, Pedro J. Garcia Ruiz, Elena Muñoz Fargas, Pilar Solís Pérez, Jaime Kulisevsky Bojarsky, Aránzazu Gorospe Onisalde, Juan Andrés Burguera Hernández, Pilar Otermin Vallejo, Matilde Calopa Garriga
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 23(8)
Continuous subcutaneous apomorphine infusion (CSAI) is, at present, an alternative option for advanced Parkinson's disease (PD) with motor fluctuations. We studied the evolution of patients with PD and severe motor fluctuations long-term treated with